Urothelial Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

FDA approval · 2018-04-30
FDA Approved: DOCETAXEL — Original Application (Mylan Institutional LLC)
The FDA approved Mylan Institutional LLC's original application for a generic docetaxel anhydrous product (ANDA208859).